JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 24, 2005; DOI: 10.1124/jpet.105.084822


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.084822v1
315/1/16    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spencer, C. I.
Right arrow Articles by Sham, J. S.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spencer, C. I.
Right arrow Articles by Sham, J. S.K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*LITHIUM COMPOUNDS
*LITHIUM, ELEMENTAL
*SODIUM


Received for publication February 11, 2005.
Revised June 17, 2005.
Accepted for publication June 20, 2005.

Mechanisms underlying the effects of the pyrethroid, tefluthrin, on action potential duration in isolated rat ventricular myocytes

C. Ian Spencer 1* James S.K. Sham 1

1 The Johns Hopkins Medical Institutions

* Address correspondence to: E-mail: cspencer{at}jhmi.edu

Abstract

Due to increased global usage, acute exposures to pyrethroid insecticides in man are of clinical concern. Pyrethroids have a primary mode of action that involves interference with the inactivation of Na+ currents (INa) in excitable cells, which may include cardiac myocytes. To investigate the possible cardiac toxicity of these agents, we have examined the effects of a type-1 pyrethroid, tefluthrin, on isolated rat ventricular myocytes. Under whole-cell current-clamp, tefluthrin prolonged the mean action potential duration (APD90) by 216 ± 34 % in 19 myocytes isolated from 14 hearts. About one third of this prolongation was apparently due to persistent INa, with the balance associated with spontaneous cytosolic Ca2+ waves, and Na+-Ca2+ exchange. In some action potentials, tefluthrin also activated early afterdepolarizations (EADs). Using a selected EAD-containing action potential clamp, we observed that EADs could evoke a Cd2+-sensitive membrane current (IEAD) that triggered secondary SR Ca2+ release. The notion that EADs could stimulate Ca2+ current was strengthened by the persistence of IEAD in myocytes exposed to extracellular Li+ and Sr2+ ions, employed to minimize Na+-Ca2+ exchange and SR Ca2+ release, respectively. Tefluthrin inhibited IEAD by approximately 10%. Taken together, our results support an arrhythmogenic model whereby tefluthrin exposure stimulated Na+ influx, provoking cellular Ca2+ overload by reverse Na+-Ca2+ exchange. During Ca2+ waves, forward Na+-Ca2+ exchange prolonged the action potential markedly, and kindled EADs by permitting the reactivation of Ca2+ current. Similar mechanisms may be involved in pyrethroid toxicity in-vivo, and in type-3 long QT syndrome, wherein Na+ channel mutations prolong INa.


Key words: action potential duration, arrhythmogenesis, early afterdepolarization, pyrethroid, sodium calcium exchange, sodium channel





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.